Trial Profile
Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 28 Jul 2006 Status change
- 07 Nov 2005 New trial record.